Brajendra Kumar Singh

Dr. Brajendra Kumar Singh


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
SKSumit Kumar
Sumit Kumar
AAAditi Arora
Aditi Arora
VMVipin K. Maikhuri
Vipin K. Maikhuri
ACAnkita Chaudhary
Ankita Chaudhary
RKRajesh Kumar
Rajesh Kumar
DMDivya Mathur
Divya Mathur
Chromones are well known as fundamental structural elements found in numerous natural compounds and medicinal substances.

7 September 2020 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
PKPrashant Kumar
Prashant Kumar
SDSriparna Dutta
Sriparna Dutta
SKSandeep Kumar
Sandeep Kumar
VBVijay Bahadur
Vijay Bahadur
EEErik Van Der Eycken
Erik Van Der Eycken
BSBrajendra Kumar Singh
Brajendra Kumar Singh
This review sheds light on the use of aldehydes in the selective acylation of arene, heteroarene and alkyl (sp3, sp2and sp) C–H bonds by proficient utilization of the C–H activation strategy.

2 January 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
SKSumit Kumar
Sumit Kumar
AAAditi Arora
Aditi Arora
SSShivani Sapra
Shivani Sapra
RKRajesh Kumar
Rajesh Kumar
BSBrajendra Kumar Singh
Brajendra Kumar Singh
SSSunil K. Singh
Sunil K. Singh
Thiazolines and their derivatives hold significant importance in the field of medicinal chemistry due to their promising potential as pharmaceutical agents.

1 April 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
ASAnil K. Singh
Anil K. Singh
VRVinoth Rajendran
Vinoth Rajendran
APAkansha Pant
Akansha Pant
PGPrahlad C. Ghosh
Prahlad C. Ghosh
NSNeelu Singh
Neelu Singh
Brijesh RathiBrijesh Rathi
Brijesh Rathi

26 October 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAnil K. Singh
Anil K. Singh
SRSumit Rathore
Sumit Rathore
YTYan Tang
Yan Tang
NGNathan E. Goldfarb
Nathan E. Goldfarb
BDBen M. Dunn
Ben M. Dunn
Brijesh RathiBrijesh Rathi
Brijesh Rathi
A novel class of phthalimides functionalized with privileged scaffolds was designed, synthesized and evaluated as potential inhibitors of plasmepsin 2 (Ki: 0.99 ± 0.1 μM for 6u) and plasmepsin 4 (Ki: 3.3 ± 0.3 μM for 6t), enzymes found in the digestive vacuole of the plasmodium parasite and considered as crucial drug targets. Three compounds were identified as potential candidates for further development. The listed compounds were also assayed for their antimalarial efficacy against chloroquine (CQ) sensitive strain (3D7) of Plasmodium falciparum. Assay of twenty seven hydroxyethylamine derivatives revealed four (5e, 6j, 6o and 6s) as strongly active, which were further evaluated against CQ resistant strain (7GB) of P. falciparum. Compound 5e possessing the piperidinopiperidine moiety exhibited promising antimalarial activity with an IC50 of 1.16 ± 0.04 μM. Further, compounds 5e, 6j, 6o and 6s exhibited low cytotoxic effect on MCF-7 cell line. Compound 6s possessing C2 symmetry was identified as the least cytotoxic with significant antimalarial activity (IC50: 1.30 ± 0.03 μM). The combined presence of hydroxyethylamine and cyclic amines (piperazines and piperidines) was observed as crucial for the activity. The current studies suggest that hydroxyethylamine based molecules act as potent antimalarial agent and may be helpful in drug development.